Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> PFIZER Latest News

MAY 31, 2014 - Yahoo! News

A Must Read - Share

Two experimental AstraZeneca drugs show promise in ovarian cancer

(Reuters) - A combination of two drugs developed by AstraZeneca Plc, olaparib and cediranib, was shown in a mid-stage study to nearly double the length of time certain ovarian cancer patients lived without their disease getting worse. After spurning a $118 billion takeover approach from Pfizer Inc, Britain's AstraZeneca is aiming to show investors at this weekend's meeting of the American Society of Clinical Oncology in Chicago that its pipeline of cancer drugs offers an opportunity for future sales growth. The 90-patient study is the first to look at a drug that blocks a cell ... Read More

Tags: Two experimental AstraZeneca drugs show promise in ovarian cancer,  Pfizer Latest News